While defective CFHR5 may contribute to atypical hemolytic uremic syndrome, CFHR1 has been shown to be downregulated in tissue from LUAD tumors compared to healthy adjacent tissue. This evidence concerns the gene CFHR1 and atypical hemolytic-uremic syndrome.